CMV IgM
In vitro diagnostic medical device for assisting in the screening of CMV infection
CMV remains latent in the body for life after infection. While it usually causes no significant symptoms in healthy individuals, it can reactivate and cause complications when the immune system is weakened. Pregnant women may experience little to no symptoms, but the virus can be transmitted to the fetus through the placenta, potentially leading to miscarriage, stillbirth, or congenital infection such as hearing loss. Additionally, CMV poses a significant risk during blood transfusions and organ transplants, making it a critical consideration.
- Diagnosis diseases
- Cytomegalovirus (CMV) infection
Available Instruments
About Using Reagent
-
Sample Types
Whole Blood, Serum, Plasma -
Reaction Time
12 mins -
Detection Range
Qualitative (Positive/Negative/Indeterminate) -
Indication
Cytomegalovirus (CMV) infection
In Your Medical Field
The CMV IgM test is used to detect acute CMV infections. IgM antibodies are produced during the early stages of infection, making them an important marker for screening acute infections. Additionally, IgM antibodies may also appear when a latent virus is reactivated, helping to assess the reactivation of the virus.